Funding to Advance the Development and Use of Non-Animal Methods

The Science Consortium regularly offers awards, including for travel grants, inhalation toxicity, and 3D tissue models. Check back for future award announcements.

****

In cases where promising in vitro or in silico techniques require additional development or validation in order to gain regulatory acceptance, PETA Science Consortium International and its members assist in providing funding for this work. Science Consortium members have contributed millions of euros towards improving and implementing non-animal research methods. Projects funded by Science Consortium members include the advancement of quantitative structure-activity relationship (QSAR) models to estimate chemical carcinogenicity and toxicity and other non-animal models to assess acute and subchronic toxicity, skin sensitisation and irritation, and endocrine activity, some of which are described below.

“PETA has been at the technical forefront of the animal protection community in its campaign to replace animal methods with in vitro methods in regulatory toxicity testing. Importantly, they have backed up their activities with real dollars to support the development of non-animal methods.” -Dr Rodger Curren Co-founder and CEO Institute for In Vitro Sciences

Dr Amy Clippinger, director of the Consortium, and Mitch Klausner, former president of MatTek Corporation, discuss collaborations

Dr Amy Clippinger, director of the Consortium, and Erin Hill, president of the Institute for In Vitro Sciences, discuss collaborations